Tregitope Peptides: The Active Pharmaceutical Ingredient of IVIG?
Anne S. De Groot(Providence College), William J. Martin(St. Jude Children's Research Hospital), Leslie P. Cousens(Providence College), Federico Mingozzi(Spark Therapeutics (United States))
Cited by 23
Related Papers
The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1
|Immunity|2009|750
Overcoming Preexisting Humoral Immunity to AAV Using Capsid Decoys
|Science Translational Medicine|2013|346
Whole body correction of mucopolysaccharidosis IIIA by intracerebrospinal fluid gene therapy
|Journal of Clinical Investigation|2013|232
Engineered AAV vector minimizes in vivo targeting of transduced hepatocytes by capsid-specific CD8+ T cells
|Blood|2013|160
Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase
|Science Translational Medicine|2017|133